| Literature DB >> 35078401 |
Ksenija Sevcenko1, Ingrid Lindgren2,3.
Abstract
BACKGROUND: Virtual Reality (VR) training is emerging in the neurorehabilitation field. Technological advancement is often faster than clinical implementation. Previous reviews stressed the study design and methodological weaknesses of research in the field of VR for neurorehabilitation. Clinically relevant conclusions on implementation in particular patient groups are needed. The aim was to update the existing knowledge with the recent evidence on the effects of VR training on functional ability of patients with stroke and Parkinson's Disease (PD). Secondary objective was to analyze the aspects of usability of VR intervention in these populations.Entities:
Keywords: Healthy aging; Parkinson’s disease; Rehabilitation; Stroke; Telerehabilitation; Virtual reality exposure therapy
Year: 2022 PMID: 35078401 PMCID: PMC8903585 DOI: 10.1186/s11556-022-00283-3
Source DB: PubMed Journal: Eur Rev Aging Phys Act ISSN: 1813-7253 Impact factor: 3.878
Fig. 1PRISMA flowchart for search results
Descriptive characteristics and findings of included studies in stroke subcategory
| Sample | Intervention | Comparison | Outcome | Test | Results | Conclusion | User feedback / follow-up info | ||
|---|---|---|---|---|---|---|---|---|---|
| [ | Adomaviciene 2019 RCT | N=42 Subacute Mean age= 64.6 | VR Kinect + conventional 2 weeks 5 times/ week | Conventional with robot-assisted trainer “Armeo Spring” 2 weeks 5 times/ week | UE mobility Function* Psycho-emotional | FMA, MAS BBT, HTT ROM, FIM HAD | No between group difference in FIM, but p<0.05 in self-care in VR. UE function significant improvement p<0.05 in both groups VR p<0.05 in HAD | Both groups improved in function, UE mobility and cognitive abilities. | Great user satisfaction, improved psycho-emotional state in VR/ No follow-up |
| [ | Fishbein 2019 RCT | N=22 Chronic Mean age= 65.2 | VR dual task walking 4weeks 2 times/ week | Conventional treadmill single task walking 4weeks 2 times/ week | Gait Balance Function | 10MWT, TUG FRT, BBS ABC | VR p<0.01 in BBS, FRT, 10MWT, ABC | VR is effective in improvement of balance, gait and function. Advised combination with conventional training with multitasking | Follow-up 4 weeks – effect maintained |
| [ | Kiper 2018 RCT | N = 136 Chronic, subacute Mean age= 63.9 | VR + conventional 4 weeks 5 times/week | Conventional 4 weeks 5 times/week | UE mobility Function | FMA FIM NIHSS ESAS | VR + conventional p<0.05 in all outcomes | VR combined with conventional has greater effect on UE function | No follow-up |
| [ | Askin 2018 RCT | N=40 Chronic Mean age= 54.9 | VR Kinect + conventional 4 weeks 5 times/week | Conventional 4 weeks 5 times/week | UE mobility Function | FMA, MAS BBT, MI ROM | VR p<0.05 in all outcomes Between group difference VR p<0.05 in FMA, MI, ROM | VR as an effective addition to conventional therapy for UE function and ROM improvement | Good response to VR, great user satisfaction/ No follow-up |
| [ | Lee MM 2018 RCT | N= 30 Subacute Mean age= 61.6 | VR Wii + conventional 5 weeks 3 times/week | Conventional 5 weeks 3 times/week | UE function Balance | MFT FRT | Both groups p<0.05 in all outcomes. Between group difference p<0.05 in VR in balance, UE function | VR is effective for postural balance and UE function if combined with conventional | No follow-up |
| [ | Schuster-Ampf 2018 RCT | N = 54 Chronic Mean age = 61.2 | VR 4 weeks 4 times/week | Conventional 4 weeks 4 times/week | UE function Dexterity QoL ADL | BBT CAHAI SIS BI | Both groups p<0.05 in BBT, CAHAI, SIS No between group difference in all outcomes, except for SIS p<0.05 in VR | VR as an effective alternative to conventional therapy in UE function, ADL, QoL. Groups improved more in first 2 weeks. | Greater improvement and response to VR in less impaired / No follow-up |
| [ | Utkan-Karasu 2018 RCT | N=23 Chronic, subacute Mean age= 63.2 | VR Wii 4 weeks 5 times/week | Conventional 4 weeks 5 times/week | Balance Function | BBS, FRT FIM, TUG | Both groups p<0.05 in all outcomes Between group difference VR p<0.05 in BBS, FRT, FIM | VR is an effective additional intervention for improvement of function, balance, independence | Follow-up 4 weeks – effect maintained |
| [ | Lee HC 2017 RCT | N= 47 Chronic Mean age= 57.6 | VR Kinect + conventional 6 weeks 2 times/week | Conventional 6 weeks 2 times/week | Balance ADL QoL Satisfaction, feasibility | BBS, FRT, TUG BI, ABC SIS | Both groups p<0.05 in BBS, TUG No between group difference in other outcomes | VR combined with conventional is effective for balance training | Great user satisfaction in VR/ Follow-up 3 months – effect maintained |
| [ | Brunner 2017 RCT | N=112 Subacute Mean age= 62 | VR 4 weeks4 times/week | Conventional 4 weeks 4 times/week | UE mobility Function ADL | ARAT BBT FIM | Both groups p<0.01 in all outcomes No between group difference | VR as effective as conventional for UE function. Entertaining alternative to standard rehabilitation | Great user satisfaction in VR/ Follow-up 3 months – effect maintained |
| [ | Adie 2017 RCT | N=209 Subacute Mean age= 67.3 | VR Wii 6 weeks 7 times/week | Conventional 6 weeks 7 times/week | UE mobility Function QoL Cost-effect | ARAT MRS SIS EQ-5D-3L | Both groups p<0.05 in ARAT, EQ 5D 3L No between group difference | VR not superior than conventional, but exciting. Cost-effect - more expensive than home exercise. | Good acceptability of VR/ Follow-up 6 months – no between group difference, but improved health state and arm function |
*Function here refers to general functional ability, motor function by functional assessment tools. The terminology varies between the studies
: 10MWT 10 meter Walk Test, ABC Activity-specific BalanceConfidence scale, ARAT Action Research Arm Test, BBS Berg Balance Scale, BBT Box and Block Test, BI Barthel Index, CAHAI Chedoke McMaster Arm and Hand Activity Inventory, ESAS Edmonton Symptom Assessment Scale, EQ-5D-3L Quality of Life measure, FIM Functional Independence Measure, FMA Fugl-Meyer Assessment, FRT Functional Reach Test, HAD Hospital Anxiety and Depression scale, HTT Hand-Tapping Test, MAS Modified Ashworth Scale, MI Motricity Index, MFT Manual Function Test, MRS Modified Rankin Scale, NIHSS National Institute of Health Stroke Scale, ROM Range of Motion, SIS Stroke Impact Scale, TUG Timed Up and Go test, UE upper extremity
Descriptive characteristics and findings of included studies in Parkinson’s disease subcategory
| Sample | Intervention | Comparison | Outcome | Test | Results | Conclusion | User feedback/ follow-up info | ||
|---|---|---|---|---|---|---|---|---|---|
| [ | Pazzaglia 2020 RCT | N=51 Mean age= 71 | VR (Nirvana) 6 weeks 3 times/week | Conventional 6 weeks 3 times/week | Balance UE function QoL Satisfaction | BBS, DGI DASH SF36 | VR p<0.05 in all outcomes Conventional only p<0.05 in DASH Between group difference in satisfaction, fatigue VR p<0.05 | VR more effective than conventional for improvement in function and QoL in safe and stimulating environment | Great user satisfaction in VR/ No follow-up |
| [ | Santos 2019 RCT | N=45 Mean age= 64.3 | 1.VR Wii 2.VR+ conventional 8 weeks 2 times/week | Conventional 8 weeks 2 times/week | Balance Gait Function* QoL | BBS DGI TUG PDQ39 | Both groups p<0.05 in BBS, TUG, DGI No between group difference | Combined VR+ conventional has largest effect in all variables. VR as an effective addition to rehabilitation | No follow-up |
| [ | Feng 2019 RCT | N= 28 Mean age= 67.2 | VR 12 weeks 5 times/week | Conventional 12 weeks 5 times/week | Balance Gait Function | BBS TUG, FGA UPDRS | Both groups BBS,TUG, FGA p<0.05 Between group p<0.05 (VR favor) | VR is promising intervention for balance, gait, mobility. Improved self-care ability | No follow-up |
| [ | Ferraz 2018 RCT | N=62 Mean age= 69 | VR Kinect 8 weeks 3 times/week | 1.Aerobic (bike) 2.Conventional (functional) 8 weeks 3 times/week | Physical capacity Gait Function QoL Depression | 6MWT SST 10MWT WHODAS PDQ39 GDS | All groups p<0.05 in 6MWT, SST, WHODAS VR p<0.05 in 10MWT, PDQ39 No between group difference | VR improves walking capacity in PD. All 3 interventions improved gait, functionality | No follow-up |
| [ | De Melo 2018 RCT | N=37 Mean age= 62.3 | VR Kinect 4 weeks 3 times/week | 1.Treadmill 2.Conventional 4 weeks 3 times/week | Gait Function Physical capacity | 6MWT Borg scale sp02 | VR p<0.05 in 6MWT, Borg No between group difference in VR and treadmill | VR improved walking speed, distance, temporal gait variables, less fatigue. Not proven as effective as treadmill for physical fitness. Combination suggested | VR perceived enjoyable, encouraging/ No follow-up |
| [ | Ribas 2017 RCPT | N=20 Mean age= 61 | VR Wii 12 weeks 2 times/week | Conventional 12 weeks 2 times/week | Balance Fatigue Function QoL | BBS FSS 6MWT PDQ39 | VR p<0.05 in BBS, FSS No between group difference in functional capacity | VR is effective in enhancing balance, reducing fatigue after 12 weeks | Follow-up 4 weeks with doing only ADL exercises - no long-term effect |
| [ | Gandolfi 2017 RCT | N=71 Mean age= 68.7 | VR Wii (at home) 7 weeks 3 times/week | Conventional (at clinic) 7 weeks 3 times/week | Balance ADL Gait Cost-effect Satisfaction | BBS, DGI ABC 10MWT | Both groups p<0.05 in DGI,ABC,10MWT Between group difference VR p<0.05 for BBS, conventional p<0.05 for DGI. | VR (with carer) is feasible alternative to in-clinic VR has lower treatment and equipment cost | Same level of satisfaction in both groups/ Follow-up 4 weeks – effective. |
| [ | Yang 2016 RCT | N= 23 Mean age= 74 | VR 6 weeks 2 times/week | Conventional 6 weeks 2 times/week | Balance Gait Function QoL | BBS, DGI TUG UPDRS PDQ39 | Both groups p<0.05 in all outcomes No between group difference in any outcome | VR as effective as conventional in balance, motor, gait, QoL. Interesting addition to home program. | Follow-up 2 weeks - no between group difference. |
*Function here refers to general functional ability, motor function by functional assessment tools. The terminology varies between the studies
: 6 MWT 6 minute Walk Test, 10MWT 10 meter Walk Test, ABC Activity-specific Balance Confidence scale, BBS Berg Balance Scale, DASH Disability of Arm, Shoulder and Hand Q, DGI Dynamic Gait Index, GDS 15-item Geriatric Depression Scale, FGA Functional Gait Assessment, FSS Fatigue Severity Scale, PDQ39 39-item Parkinson Disease Questionnaire, SF-36 The Short Form Health Survey, SST Sit-to-Stand Test, TUG Timed Up and Go test, UPDRS Unified Parkinson Disease Rating Scale, WHODAS WHO Disability Assessment Sscale